Andrew M. Oh

Chief Financial Officer, Rubius Therapeutics (United States).

Companies

Syros Pharmaceuticals, Inc.Board member Sep 19, 2022 to Jun 7, 2024¹
Rubius Therapeutics (United States)Chief financial officer Jul 17, 2018 to May 19, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Syros Pharmaceuticals, Inc.16,000 shares³Jun 5, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 5, 2024Granted 4,000 shares of Syros Pharmaceuticals, Inc.³
Jun 1, 2023Granted 4,000 shares of Syros Pharmaceuticals, Inc.⁴
Sep 16, 2022Granted 8,000 shares of Syros Pharmaceuticals, Inc.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSyros Pharmaceuticals, Inc., Board member
2
SEC EDGARRubius Therapeutics (United States), Chief financial officer
3
SEC EDGARSyros Pharmaceuticals, Inc. shares after the filing of Jun 5, 2024
4
SEC EDGARForm 4 filed Jun 2, 2023
5
SEC EDGARForm 4 filed Sep 19, 2022